Difference between revisions of "Neurodegenerative diseases"

From Libre Pathology
Jump to navigation Jump to search
(more)
Line 2: Line 2:


==Overview==
==Overview==
They are essentially progressive and selective neuron loss.  Clinically, they are not unique.  They are defined by molecular pathology.<ref name=pmid19918325>{{cite journal |author=Dickson DW |title=Neuropathology of non-Alzheimer degenerative disorders |journal=Int J Clin Exp Pathol |volume=3 |issue=1 |pages=1–23 |year=2009 |pmid=19918325 |pmc=2776269 |doi= |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776269/?tool=pubmed}}</ref>
*They are essentially progressive and selective neuron loss.   
*Clinically, they are not unique, e.g. dementia can be caused by several diseases (with different molecular etiologies).   
*They are defined by molecular pathology.<ref name=pmid19918325>{{cite journal |author=Dickson DW |title=Neuropathology of non-Alzheimer degenerative disorders |journal=Int J Clin Exp Pathol |volume=3 |issue=1 |pages=1–23 |year=2009 |pmid=19918325 |pmc=2776269 |doi= |url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776269/?tool=pubmed}}</ref>
**The diseases are due to the accumulation of abnormal protein.
***The amino acid sequence of the protein may be completely normal.  The problem may just be folding/protein conformation.


Molecular schema of neurodegenerative disorders:<ref name=pmid19918325/>
Molecular schema of neurodegenerative disorders:<ref name=pmid19918325/>
Line 20: Line 24:
*Pick's disease.
*Pick's disease.


Synucleinopathies:
Synucleinopathies:<ref name=pmid18855701>{{Cite journal  | last1 = Uversky | first1 = VN. | title = Alpha-synuclein misfolding and neurodegenerative diseases. | journal = Curr Protein Pept Sci | volume = 9 | issue = 5 | pages = 507-40 | month = Oct | year = 2008 | doi =  | PMID = 18855701 }}</ref>
*Parkinson disease.
*Parkinson disease.
*Dementia with Lewy bodies.
*Dementia with Lewy bodies.
Line 104: Line 108:
*TDP-43.
*TDP-43.


==General DDx of dementia==
==Clinical perspective (becoming obsolete)==
*Alzheimer's dementia.
===General (mostly useless) DDx===
*Alzheimer's dementia - most common.
*Vascular.
*Vascular.
**Multi-infarct dementia.
**Multi-infarct dementia.
Line 114: Line 119:
*Multisystem atrophy.
*Multisystem atrophy.


===Mnemonic===
Mnemonic ''VITAMIN D VEST'':<ref>TN06 PS19</ref>
Mnemonic ''VITAMIN D VEST'':<ref>TN06 PS19</ref>
*Vitamin deficiency (B12, folate, thiamine).
*Vitamin deficiency (B12, folate, thiamine).
Line 128: Line 134:
*Toxins (alcohol).
*Toxins (alcohol).


==Lewy body dementia==
===Functional anatomy of dementia===
*Hippocampus (essential for forming new memories).
*Frontal lobe (essential for retrieval of memories).
 
==Lewy body diseases==
DDx:
*Parkinson's disease.
*Dementia with Lewy bodies.
 
Etiology:
*Alpha-synuclein.
 
Clinical features of Dementia with Lewy bodies:
*Parkinsonian features.
*Parkinsonian features.
*Hallucinations (visual).
*Hallucinations (visual).
*Progressive cog. decline with fluctuations.
*Progressive cognitive decline with fluctuations.


==Multiple system atrophy==
==Multiple system atrophy==
*Alpha-synuclein-rich glial cytoplasmic inclusions - finding at autopsy.<ref name=pmid18825660>{{Cite journal  | last1 = Wenning | first1 = GK. | last2 = Stefanova | first2 = N. | last3 = Jellinger | first3 = KA. | last4 = Poewe | first4 = W. | last5 = Schlossmacher | first5 = MG. | title = Multiple system atrophy: a primary oligodendrogliopathy. | journal = Ann Neurol | volume = 64 | issue = 3 | pages = 239-46 | month = Sep | year = 2008 | doi = 10.1002/ana.21465 | PMID = 18825660 }}</ref>
Clinical findings variable:
**Alpha-synuclein is implicated in a number of neurodegenerative diseases.<ref name=pmid18855701>{{Cite journal  | last1 = Uversky | first1 = VN. | title = Alpha-synuclein misfolding and neurodegenerative diseases. | journal = Curr Protein Pept Sci | volume = 9 | issue = 5 | pages = 507-40 | month = Oct | year = 2008 | doi =  | PMID = 18855701 }}</ref>
*Parkinsonism (stiatonigral degeneration).
*Ataxia (olivo-panto-cerebellar degeneration).
 
Etiology:
*Alpha-synuclein-rich glial cytoplasmic inclusions - finding at autopsy.<ref name=pmid18825660>{{Cite journal  | last1 = Wenning | first1 = GK. | last2 = Stefanova | first2 = N. | last3 = Jellinger | first3 = KA. | last4 = Poewe | first4 = W. | last5 = Schlossmacher | first5 = MG. | title = Multiple system atrophy: a primary oligodendrogliopathy. | journal = Ann Neurol | volume = 64 | issue = 3 | pages = 239-46 | month = Sep | year = 2008 | doi = 10.1002/ana.21465 | PMID = 18825660 }}</ref>  
**Inclusions in oligodendrocytes.<ref>MUN. 16 November 2010.</ref>


==Progressive supranuclear palsy==
==Progressive supranuclear palsy==
Line 196: Line 219:
*[http://commons.wikimedia.org/wiki/File:SpongiformChangeCJD.jpg CJD (WC)].
*[http://commons.wikimedia.org/wiki/File:SpongiformChangeCJD.jpg CJD (WC)].
*[http://commons.wikimedia.org/wiki/File:VCJD_Tonsil.jpg vCJD - IHC (WC)].
*[http://commons.wikimedia.org/wiki/File:VCJD_Tonsil.jpg vCJD - IHC (WC)].


==See also==
==See also==

Revision as of 22:33, 16 November 2010

Neurodegenerative diseases is a big part of neuropathology.

Overview

  • They are essentially progressive and selective neuron loss.
  • Clinically, they are not unique, e.g. dementia can be caused by several diseases (with different molecular etiologies).
  • They are defined by molecular pathology.[1]
    • The diseases are due to the accumulation of abnormal protein.
      • The amino acid sequence of the protein may be completely normal. The problem may just be folding/protein conformation.

Molecular schema of neurodegenerative disorders:[1]

 
 
 
 
 
 
Neurodegenerative
disorders
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amyloidoses
 
Tauopathies
 
α-synucleinopathies
 
TDP-43
 

Common diseases

Amyloidoses:

  • Alzheimer disease (Abeta).
  • Creutzfeldt-Jakob disease (PrP).

Taupathies:

  • Progressive supranuclear palsy.
  • Pick's disease.

Synucleinopathies:[2]

  • Parkinson disease.
  • Dementia with Lewy bodies.
  • Multiple system atrophy.

TDP-43 proteinopathies:

  • Amyotrophic alteral sclerosis.
  • Frontotemporal lobar degeneration with ubiquitinated inclusions.

Table

Disease/pathology/clinical correlation based on Dickson:[1]

Disease Mutated protein Distribution Clinical Image
Alzheimer disease Abeta (mutated APP) corticolimbic, usu.
spares occipital
dementia Image?
Creutzfeldt-Jakob disease PrPres (mutated PrP) cortical & basal ganglia dementia (rapid progression),
movement disorder
Image?
Progressive supranuclear palsy tau 4R basal ganglia, brainstem parkinsonism Image?
Pick disease tau 3R corticolimbic dementia + focal
cortical syndrome
Image?
Parkinson disease alpha-synuclein brainstem parkinsonism Image?
Dementia with
Lewy bodies
alpha-synuclein corticolimbic, brainstem dementia + parkinsonism Image?
Multiple system atrophy alpha-synuclein basal ganglia, brainstem, cerebellum parkinsonism, ataxia Image
Amyotrophic lateral
sclerosis (ALS)
TDP-43 motor neurons spasticity, weakness Image
Frontotemporal lobar
degeneration with
ubiquitinated inclusions
TDP-43 cortex, basal ganglia dementia, focal cortical syndromes Image?

IHC

  • AT-8 = stains phosphorylated tau.[3]
  • p62; poli-ubiquitin-binding protein p62.[3]
  • TDP-43.

Clinical perspective (becoming obsolete)

General (mostly useless) DDx

  • Alzheimer's dementia - most common.
  • Vascular.
    • Multi-infarct dementia.
  • Parkinson's associated dementia.
  • Lewy body dementia.
  • Alcohol-related dementia.
  • Fronto-temporal dementia (Pick disease).
  • Multisystem atrophy.

Mnemonic

Mnemonic VITAMIN D VEST:[4]

  • Vitamin deficiency (B12, folate, thiamine).
  • Infection (HIV).
  • Trauma.
  • Anoxia.
  • Metabolic (Diabetes).
  • Intracranial tumour.
  • Normal pressure hydrocephalus.
  • Degenerative (Alzheimer's, Huntington's, CJD).
  • Vascular.
  • Endocrine.
  • Space occupying lesion (chronic subdural hematoma).
  • Toxins (alcohol).

Functional anatomy of dementia

  • Hippocampus (essential for forming new memories).
  • Frontal lobe (essential for retrieval of memories).

Lewy body diseases

DDx:

  • Parkinson's disease.
  • Dementia with Lewy bodies.

Etiology:

  • Alpha-synuclein.

Clinical features of Dementia with Lewy bodies:

  • Parkinsonian features.
  • Hallucinations (visual).
  • Progressive cognitive decline with fluctuations.

Multiple system atrophy

Clinical findings variable:

  • Parkinsonism (stiatonigral degeneration).
  • Ataxia (olivo-panto-cerebellar degeneration).

Etiology:

  • Alpha-synuclein-rich glial cytoplasmic inclusions - finding at autopsy.[5]
    • Inclusions in oligodendrocytes.[6]

Progressive supranuclear palsy

General

  • AKA Steele-Richardson-Olszewski syndrome.
  • Diagnosis: clinical.[7]

Microscopic

Features:[1][7][8]

  • Globose neurofibrillary tangles in neurons.
  • Coiled bodies in oligodendrocytes.

Huntington disease

General

  • Autosomal dominant inheritance.
  • Mutation: unstable CAG repeat.[9]

Gross

  • Missing caudate.[10]

Image: Huntington's disease (ouhsc.edu).

Binswanger's disease

General

  • Multi-infarct dementia affecting subcortical white matter.
  • Waste-basket diagnosis; diagnosed if CADASIL and amyloidosis have been excluded.
  • Diagnosis has been controversial -- most with this entity (in the past) were diagnosed with Alzheimer's disease.

Microscopic

Features:

  • Subcortical lesions that replace the myelin consisting of macrophages.

Prion diseases

Etiology:[11]

  • Misfolded cell-surface protein called PrP(C).

Includes:[11]

  • Creutzfeldt-Jakob disease (CJD).
  • Sporadic fatal insomnia (sFI).

Creutzfeldt-Jakob disease

General

  • Commonly abbreviated as CJD.
  • Rare.
  • Incurable disease.
  • Usually diagnosed clinically.
    • Characteristic findings:
      • Very rapid decline (3-4 months).
      • Characteristic (cortex findings on) neuroradiology.

Variant Creutzfeldt-Jakob disease (vCJD)

  • Associated with bovine spongiform encephalopathy.
  • Should sample: spleen, lymph nodes, tonsils.[12]

Microscopic

Features:

  • Spongy appearance (cytoplasmic vacuolization[13]).

Images:

See also

References

  1. 1.0 1.1 1.2 1.3 Dickson DW (2009). "Neuropathology of non-Alzheimer degenerative disorders". Int J Clin Exp Pathol 3 (1): 1–23. PMC 2776269. PMID 19918325. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776269/?tool=pubmed.
  2. Uversky, VN. (Oct 2008). "Alpha-synuclein misfolding and neurodegenerative diseases.". Curr Protein Pept Sci 9 (5): 507-40. PMID 18855701.
  3. 3.0 3.1 Seelaar H, Klijnsma KY, de Koning I, et al. (May 2010). "Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration". J. Neurol. 257 (5): 747–53. doi:10.1007/s00415-009-5404-z. PMC 2864899. PMID 19946779. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864899/.
  4. TN06 PS19
  5. Wenning, GK.; Stefanova, N.; Jellinger, KA.; Poewe, W.; Schlossmacher, MG. (Sep 2008). "Multiple system atrophy: a primary oligodendrogliopathy.". Ann Neurol 64 (3): 239-46. doi:10.1002/ana.21465. PMID 18825660.
  6. MUN. 16 November 2010.
  7. 7.0 7.1 URL: http://emedicine.medscape.com/article/1151430-overview. Accessed on: 11 November 2010.
  8. Williams DR, Lees AJ (March 2009). "Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges". Lancet Neurol 8 (3): 270–9. doi:10.1016/S1474-4422(09)70042-0. PMID 19233037.
  9. Kumar P, Kalonia H, Kumar A (2010). "Huntington's disease: pathogenesis to animal models". Pharmacol Rep 62 (1): 1–14. PMID 20360611.
  10. URL: http://moon.ouhsc.edu/kfung/jty1/NeuroTest/Q07-Ans.htm. Accessed on: 29 October 2010.
  11. 11.0 11.1 Watts JC, Balachandran A, Westaway D (March 2006). "The expanding universe of prion diseases". PLoS Pathog. 2 (3): e26. doi:10.1371/journal.ppat.0020026. PMC 1434791. PMID 16609731. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434791/.
  12. Burton, Julian L.; Rutty, Guy N. (2010). The Hospital Autopsy A Manual of Fundamental Autopsy Practice (3rd ed.). Oxford University Press. pp. 83. ISBN 978-0340965146.
  13. URL: http://moon.ouhsc.edu/kfung/jty1/opaq/PathQuiz/N0I002-PQ01-M.htm. Accessed on: 19 October 2010.